Detail of "10246-75-0"

Reference

Characteristic changes of injection formulations

Characteristic changes of injection formulations. 4. Incompatibility of latamoxef sodium injection. Goto, Katsuhiro; Kato, Seiji; Sumiya, Sadaharu; Oishi, Hajime (Tonan Hosp., Sapporo 060, Japan). Byoin Yakugaku, 9(6), 498-504 (Japanese) 1983. CODEN: BYYADW. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) Latamoxef Na (I) [64953-12-4] injections were mixed with ~20 com. infusions and ~60 com. injections to study their compatibility (stability). Mixts. of I injections with infusions were stable for up to 24 h as judged by their changes in the pH and potency. Mixts. of I injections with Atarax-P [10246-75-0], Bisolvon [611-75-6], cepharanthin [481-49-2], FOY [56974-61-9] or Horizon [439-14-5] injections were stable for 24 h and those with neophyllin [479-18-5] injection were stable for <6 h. The stability of other mixts. varied.

Analgesic combinations

Analgesic combinations. Cooper, Stephen A. (Sandoz A.-G., Switz.). PCT Int. Appl. WO 8402273 A1 21 Jun 1984, 17 pp. DESIGNATED STATES: W: AU, DK, HU, JP. (English). (World Intellectual Property Organization). CODEN: PIXXD2. CLASS: IC: A61K031-495; A61K031-505; A61K031-62. ICI: A61K031-505, A61K031-495, A61K031-165, A61K031-19. APPLICATION: WO 83-EP326 7 Dec 1983. PRIORITY: US 82-448290 9 Dec 1982. DOCUMENT TYPE: Patent CA Section: 63 (Pharmaceuticals) Section cross-reference(s): 1 An analgesic combination for oral or rectal administration contains hydroxyine [68-88-2] or its salts and at least 1 of a nonsteroidal anti-inflammatory analgesic and/or acetaminophen [103-90-2]. Capsules were prepd. contg. 200 mg ibuprofen [15687-27-1] and 50 mg hydroxyzine pamoate [10246-75-0]. Clin. tests were given showing the synergistic effects of the combinations compared to administration of the single compds.